(Q31920812)

5 July 2017

1 reference

title

Limitations and strengths of spontaneous reports data (English)

1 reference

5 July 2017

Goldman SA

1

1 reference

5 July 2017

1 January 1998

1 reference

5 July 2017

Clinical Therapeutics

1 reference

5 July 2017

20 Suppl C

1 reference

5 July 2017

C40-4

1 reference

The ambiguity of adverse drug reactions

5 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980007-6

7 January 2021

PRE-EXISTING CONDITIONS, PLACEBO REACTIONS, AND "SIDE EFFECTS".

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980007-6

7 January 2021

Adverse nondrug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980007-6

7 January 2021

Adverse drug reactions—a matter of opinion

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980007-6

7 January 2021

The Vaccine Adverse Event Reporting System (VAERS)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980007-6

7 January 2021

Pharmacoepidemiology: current status, prospects, and problems

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980007-6

7 January 2021

False-positives in spontaneous reporting: should we worry about them?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980007-6

7 January 2021

Drug utilization study methodologies: national and international perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980007-6

7 January 2021

Spontaneous adverse drug reaction reporting vs event monitoring: a comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980007-6

7 January 2021

The detection of adverse reactions to therapeutic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980007-6

7 January 2021

Does proof of casualty ever exist in pharmacovigilance?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980007-6

7 January 2021

Adverse Effects of Newly Marketed Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980007-6

7 January 2021

10.1016/S0149-2918(98)80007-6

Identifiers

DOI

1 reference

5 July 2017

1 reference

PubMed ID

9915089